Rulemaking Process Flawed, But Making Monograph Rules Still Needs Funding
This article was originally published in The Tan Sheet
Executive Summary
The monograph program was "instituted really many, many decades ago. We've been trying to implement it since," says CDER Director Janet Woodcock. "We haven't had a much bigger pie to play with, so that's been one constraint that we've had to deal with," says center budget chief Donal Parks.
You may also be interested in...
OTC Hangover Remedy Safety On Tap For FDA Advisory Committees
CDER schedules an NDAC and DSRMAC joint meeting while also negotiating with industry stakeholders on a potential proposal for a user fee program to support FDA’s work on finalizing monographs or amending monographs with additional ingredients or indications.
OTC Hangover Remedy Safety On Tap For FDA Advisory Committees
CDER schedules an NDAC and DSRMAC joint meeting while also negotiating with industry stakeholders on a potential proposal for a user fee program to support FDA’s work on finalizing monographs or amending monographs with additional ingredients or indications.
One Step Forward, Two Steps Back: Regulatory Reform May Be Tougher On CMS Than On FDA
President-Elect Trump is putting new meaning in the catch phrase “doubling down”: promising an executive order to require agencies to withdraw two old regulations any time they issue a new one. That may be a big challenge for CMS – and also complicate some aspects of FDA’s activities.